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Yiming Wang1,2†, Xun Zhao1,3†, Adrienne O'Neil2,4, Alyna Turner2, Xingde Liu5* and Michael Berk2,6,7Abstract
Background: Depression is an independent risk factor for coronary artery disease. Autonomic instability may play a
mediating or moderating role in this relationship; however this is not well understood. The objective of this study
was to explore cardiac autonomic function and cardiac arrhythmia in depression, the correlation between
depression severity and Heart Rate Variability (HRV) related indices, and the prevalence of arrhythmia.
Methods: Individuals (n = 53) with major depression as assessed by the Diagnostic and Statistical Manual of Mental
Disorders, who had a Hamilton Rating Scale for Depression (HAMD) score ≥20 and a Zung Self-Rating Depression
Scale score > 53 were compared to 53 healthy individuals, matched for age and gender. Multichannel
Electrocardiograph ECG-92C data were collected over 24 hours. Long-term changes in HRV were used to assess the
following vagally mediated changes in autonomic tone, expressed as time domain indices: Standard deviation of the
NN intervals (SDNN), standard deviation of 5 min averaged NN intervals (SDANN), Root Mean Square of the Successive
Differences (RMSSD) and percentage of NN intervals > 50 ms different from preceding interval (pNN50). Pearson’s
correlations were conducted to explore the strength of the association between depression severity (using the SDS
and HRV related indices, specifically SDNN and low frequency domain / high frequency domain (LF/HF)).
Results: The values of SDNN, SDANN, RMSSD, PNN50 and HF were lower in the depression group compared to the
control group (P<.05). The mean value of the LF in the depression group was higher than the in control group (P<.05).
Furthermore the ratio of LF/HF was higher among the depression group than the control group (P<.05). A linear
relationship was shown to exist between the severity of the depression and HRV indices. In the depression group, the
prevalence of arrhythmia was significantly higher than in the control group (P<.05), particularly supraventricular
arrhythmias.
Conclusions: Our findings suggest that depression is accompanied by dysfunction of the cardiac autonomic nervous
system, and further, that depression severity is linked to severity of this dysfunction. Individuals with depression appear
to be susceptible to premature atrial and/or ventricular disease.
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disordersBackground
Prospective research has shown a significant relationship
between depression and cardiovascular disease (CVD)
[1]. In patients with coronary artery disease (CAD), co-
occuring depression is associated with a range of poorer
outcome measures [2-4] and a 2–4 fold increase in
cardiac mortality and morbidity [5-9]. Depression has* Correspondence: lxdwangyiming@aliyun.com
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reproduction in any medium, provided the oralso recently emerged as a risk factor for the onset of
CVD. Individuals with a history of depression are four
times more likely to have a heart attack (myocardial
infarction; MI) than those without [10]. However, the
underlying physiology of this relationship remains poorly
understood.
Data from animal models (e.g. the chronic mild stress
(CMS) model) have indicated that depression exascer-
bates stress reactivity, and is associated with autonomic
and cardiovascular dysfunction, including reduced heart
rate variability (HRV) as well as elevated heart rate (HR)td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in human populations have also reported a relationship
between cardiac autonomic dysfunction and altered car-
diovascular reactivity [14]. While the pathophysiologic
mechanisms linking cardiovascular events to depression
are unclear, there is evidence implicating lower HRV,
sympathetic tone changes, arrhythmias, and changes in
ventricular electrophysiological properties [15]. HRV in
particular is of increasing interest, due to its clinical
application [16], and has been used as an index of car-
diac autonomic functioning in patients with psychiatric
disorders, personality or communication disorders.
To date, studies examining HRV in patients with
existing CVD have produced inconsistent results. Several
studies have found that reduced HRV in patients with
post-MI depression [17,18] is linked to increased cardiac
mortality, whereas other studies have shown no relation-
ship between depression and low HRV in patients with
stable CAD [16]. Exacerbating these inconsistencies is
evidence that anxiety, which commonly co-occurs with
depression, is associated with changes to HRV, and is
implicated as an independent predictor of reduced para-
sympathetic activity in MI patients [19].
In order to elucidate the association between depression
and cardiac autonomic nervous function, a comprehensive
investigation of autonomic nervous system dysfunction in
psychiatric populations is required. Patients with depres-
sion often suffer from symptoms of autonomic nervous
system dysfunction such as palpitations occurring with a
normal sinus rhythm as measured by electrocardiogram
(ECG). Importantly, autonomic dysfunction and abnormal
microvolt T wave alternans in these patients can increase
the probability of sudden death [20]. We therefore sought
to investigate cardiac autonomic function among indivi-
duals with and without depression, to determine the
correlation between depression severity and HRV-related




The depression group consisted of 53 patients (25 male,
28 female; age range 20–65, mean 40.9 ± 10.5), who were
hospitalized for major depression in the Psychiatry
Department of the affiliated hospital of Guiyang Medical
University between March and December, 2012.
Study participants were those with a primary diagnosis
of depression. To be eligible for inclusion in the study,
all subjects met diagnostic criteria for depression as
assessed by the Structured Clinical Interview for Diagnos-
tic and Statistical Manual of the American Psychiatric
Association-IV-TR (DSM-IV-TR) Axis I disorders (SCID).
In addition, they were assessed using the Hamilton
Rating Scale for Depression (HAMD), the Zung Self-rating Depression Scale (SDS) and Hamilton Anxiety
Scale (HAMA). Inclusion criteria were a HAMD ≥ 20, a
SDS > 53 and a depression severity index range of 0.25-
1.0. Exclusion criteria included a HAMA score >14
points (to exclude patients with primary anxiety disor-
ders); a diagnosis of an organic depressive disorder or
substance dependence; or a history of any other psychi-
atric illness. Patients with a current or past history of
acute myocardial infarction (as assessed by ECG testing)
or comorbid medical conditions including diabetes
mellitus were also excluded. Anti-depressant medica-
tion usage was not an exclusion criterion, as all patients
were receiving SSRIs treatment.
The control group (n = 53, M 27, F 26; age range 20–
63, mean 42.1 ± 11.61) consisted of normal healthy
volunteers with a HAMD score <20, a HAMA score <7,
and no history of depression, anxiety or somatic disorders.Consent
All participants gave their written informed consent to
participate in the study. The procedures followed were
in accordance with the revised edition of the Declaration
of Helsinki of 1964 [21].Ethics
The study was approved by the ethics Committee on the
Guidelines for Experiment at Guiyang Medical University
(NO 04/2012).Assessment
Experiment processes
All participants were familiarized with the research
protocol. Participants were precluded from taking any
agents capable of influencing heart rate 48 hours prior
to the experiments, such as Beta Blockers, cigarettes,
alcohol, tea and coffee drinks, or from undertaking strenu-
ous exercise within 24 hours of the assessments. Prior to
the procedures, participants were asked to stay in a quiet
room and rest for 15 minutes. Electrodes were attached
and results analyzed by the same doctor.Dynamic electrocardiogram collection
Twenty four hour ambulatory ECG data for all subjects
was collected between 8:00 am to 8:00 am the next
morning. Assessment of arrythmias was conducted by a
technician who was blind to group allocation. HRV
parameter values were analyzed using the ECG-92C
multichannel electrocardiograph (Shanghai Photoelec-
tric Electronic Medical Instruments Co., Ltd.). Paroxys-
mal tachycardia was diagnosed using repeated ECG
readings (3+).
Table 1 Demographic data between the control and
depression groups (Mean ± SEM, n = 53) unless indicated
Items Control Depression
Ages (years) 42.1 ± 11.61 40.9 ± 10.5
(Ranges) 20–63 20–65
Gender (male/female) (n) 27/26 (51%/49%) 25/28 (47%/53%)
Resting SBP (mm Hg) 125 ± 20 130 ± 22
Resting DBP (mm Hg) 74 ± 9 70 ± 10
Smokers/non-smokers (n) 24/29 (45%/55%) 28/25 (53%/47%)
No significant differences in the demographic variables (age, sex, blood
pressure, smoking) between the control and depression groups,
were observed.
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The Zung Self-rating Depression Scale (SDS) is a 20-item
self-report questionnaire that was used to assess depres-
sion severity. The total raw score is calculated by summing
all items. The SDS depression severity index is calculated
by the formula “SDS Index = Raw Score/80” [22].
Time and frequency domain index absolute measures of HRV
HRV, the physiological phenomenon where the sinus
cardiac rhythm varies from the mean heart rate, is mea-
sured over a 24 hour monitoring period. It is a quan-
titative, non-invasive and highly reproducible index of
cardiac autonomic function and an important indicator
of the balance of sympathetic and parasympathetic tone.
It reflects the autonomic nervous control of heart func-
tion by a dynamic controlling effect [23]. Time-domain
analysis indices include SDNN, SDANN, RMSSD and
PNN50 by the beat-to-beat or NN intervals. The SDNN
(Standard deviation of the NN intervals) is an overall
measure of HRV size and reflects all long-term compo-
nents, indicative of dysregulation of the parasympathetic
and sympathetic nerve function. SDANN (standard
deviation of 5 min averaged NN intervals) is a sensitive
index of the variability of the average of 5 minute
periods, and reflects circadian influences including
changes in position and physical activity. Both RMSSD
(Root Mean Square of the Successive Differences) and
pNN50 (percentage of NN intervals > 50 ms different
from preceding interval) are linked to short-term changes
in HRV rather than diurnal variations, and reflect vagally
mediated changes in autonomic tone.
Frequency domain (power spectral density) analysis
indices [24,25] at different amplitudes and frequencies
describe the periodic oscillations in the decomposition
of heart rate signals. This is assessed by the area (or
power spectral density) of each component. Absolute
values are expressed in ms2. Frequency domain indices
include: the very low frequency band (VLF, <0.003-
0.04 Hz, ms2); low-frequency power (LF, 0.04–0.15 Hz,
ms2), a mixture of sympathetic and parasympathetic
activity; high-frequency power (HF, 0.15-0.4 Hz, ms2),
describing parasympathetic tone; and the low-high fre-
quency power ratio (LF/HF), which reflects the balance
of sympathetic and parasympathetic innervations. The
LF/HF ratio has been shown to be a good indicator of
the sympathovagal balance of the autonomic nervous
system [26]. HF and LF power were calculated using fast
Fourier transformation (FFT). FFT is a rapid and simple
nonparametric method, characterized by specified fre-
quency windows for the frequency components. Because
absolute values are more sensitive than normalized indi-
ces in the analysis of 24 h HRV indices, absolute values
of the direct measures were utilized and expressed in
ms2 for the purpose of this study.Statistical analyses
Key characteristics and clinical parameters were expressed
as Means (± SEM), with independent samples t-tests used
to determine differences between the depression and
control groups. Correlations between depression severity
and the HRV indices, specifically SDNN and LF/HF, were
assessed using Pearson’s analysis. SDNN reflects the total
variability over the period of recording, hence has been
shown to be the most significant prognostic value among
time domain parameters [27]. For each participant, the
presence of an arrhythmia was defined as the occurrence
of single or paired atrial and/or ventricular premature
beats as detected on the ECG. Significant between group
differences in the prevalence of arrhythmias were cal-
culated using the Chi-square test. SPSS19.0 software was
used and the level of significance was set at P<.05.
Results
Demographic features
The key characteristics of the sample are displayed in
Table 1. No statistically significant differences in demo-
graphic variables (age, sex, BP, smoking) were observed
between the control and depression groups. Those in the
depression group were slightly younger (40.9 years), had a
higher mean systolic blood pressure (BP) and lower
diastolic BP, and a higher rate of smoking than in the con-
trol group. Selective serotonin-reuptake inhibitors (SSRIs)
were routinely used to treat to patients with major depres-
sion (dosing paroxetine 40 mg/d in 15 cases, escitalopram
20 mg/d in 18 cases, sertraline 100 mg/d in 20 cases).
The time domain indices of HRV
The comparison between the time domain indices of
HRV in the two groups is illustrated in Table 2. In the
depression group, the values of SDNN, SDANN,
RMSSD, and PNN50 were significantly lower than that
of the control group (P<.05).
The frequency domain indices of HRV
The comparison between the mean frequency domain
indices of HRV for the two groups is illustrated in
Table 2 Comparison of time domain indices of HRV
(Mean ± SEM, n=53)
Indexes (ms2) Depression Control
SDNN 93.13 ± 16.12** 110.57 ± 20.10
SDANN 84.34 ± 15.46* 91.09 ± 12.69
RMSSD 38.83 ± 8.82* 43.64 ± 11.01
PNN50 11.05 ± 7.32* 14.07 ± 6.72
Note: compared to control group, *P<.05,** P<.01.
Figure 1 The correlation between Depressive severity index
and LF/HF. Pearson relativity analysis shows a positive correlation
between depressive severity index and LF/HF (P<.05, r = .335).
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higher in the depression group than the control group
(P<.05), and the value of HF was significantly lower in
the depression than the control group (P<.05).
The relationship between depression severity and HRV
indices
Associations between the SDS depression severity index
and HRV related indices are illustrated in Figures 1 & 2.
A linear relationship was evident between the depression
severity index and the value of LF/HF (Figure 1).
Pearson’s relativity analysis showed a positive correlation
between the two groups (P<.05, r = .335). A negative
correlation was observed between the depression severity
index and the value of SDNN (Figure 2; P<.05; r = −.298),
suggesting more severe depression was accompanied by a
higher mean level of cardiac autonomic dysfunction.
The prevalence of arrhythmia in depression
There was a higher prevalence of arrhythmias, including
single atrial premature beats, paired atrial premature
beats and paired ventricular premature beats in the
depressed group compared to the control group, P < .05.
(Figure 3).
Discussion
This study demonstrated that, when compared with a
healthy control group, patients hospitalized for clinical
depression exhibit altered cardiac nervous function,
evidenced by a lower high frequency domain index and
a higher low frequency domain index and LF/HF ratio.
Increases in the severity of depressive symptoms were
shown to exacerbate these trends. Arrhythmias, particu-
larly supraventricular arrhythmias, were over-represented
in depressed patients when compared to those without.Table 3 Comparison of frequency domain indices of HRV
(Mean ± SEM, n=53)
Indexes (ms2) Depression Control
LF 19.17 ± 6.48* 16.41 ± 5.15
HF 18.64 ± 4.34* 20.95 ± 5.86
LF/HF 1.05 ± 0.35* 0.86 ± 0.41
Note: compared to control group, *P<.05.The findings from this study are consistent with the
hypothesis that cardiac autonomic dysfunction is experi-
enced by individuals with depression, especially decreased
parasympathetic nerve activity (as evidenced by decreased
values of the time domain indexes). This is supported by
other studies of patients with depression that have applied
other assessment techniques. For example, Bi et.al [28]
found that patients with depression experienced auto-
nomic nervous dysfunction using sympathetic skin res-
ponse measures.
There may be a number of explanations for this
finding. A mood disorder may trigger a series of adverse
cardiovascular factors that evoke pathophysiological
changes, which have been detailed previously [29]. These
study [2-4] have demonstrated a significant relationship
between depression and cardiovascular risk factors that
are known to lead to adverse outcomes. Battacharyya
et al. [30] hypothesized that the relationship between
depression and cardiovascular risk may be explained by
enhanced parasympathetic control. We suggest that the
decreased HF and increased LF and LF/HF ratioFigure 2 The correlation between Depressive severity index
and SDNN. Pearson relativity analysis shows a negative correlation
between depressive severity index and SDNN (P<.05; r = −.298).
Figure 3 Comparison the rates of arrhythmia between the
depression and control group. Note: Chi-square test, compared to
control group, *P<.05.
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is indicative of reduced parasympathetic nerve activities
and the imbalance of sympathetic and parasympathetic
innervation, which may reflect dysregulation of sympa-
thetic and parasympathetic coordination in depression.
LF reflects the influence of sympathetic and parasympa-
thetic nervous activity on heart rate fluctuation, and has
relevance to vessel baroreflex effects. As such, enhanced
vascular baroreceptor reflex resulting from emotional
stress can induce increased LF. This is consistent with
clinical manifestations in patients with depression who
experience excessive tension, palpitation, chest tightness
and other physical symptoms. HF may represent both
vagus nerve activity and respiratory activity. However,
Berger [31] found that while vagus activity was reduced in
their group of depressed patients, there was no relationship
between parasympathetic nervous activity and the fre-
quency and rhythm of respiration. As there is a direct
effect on HRV [32], where HRV is smaller if parasympa-
thetic activity is lower and vice versa, we propose that
parasympathetic nervous activity predominantly influences
cardioregulatory function. Pathophysiological links bet-
ween depression and cardiovascular system dysfunction
include reduced HRV, changed sympathetic nerve activity,
arrhythmia, and altered ventricular electrophysiological
properties [15]. In examining HRV in depressed patients in
our study, we speculated that the relative increase in sym-
pathetic tone and corresponding reduction of parasympa-
thetic tone may be a mechanism associated with this
phenomenon and arrhythmia induction.
Our finding that a linear relationship exists between
depression severity and HRV is consistent with previous
research. Stein [33] found that cardiac patients with
severe depression experienced significantly reduced HRV
and increased mortality; a linear relationship between de-
pression severity and level of cardiac autonomic dysfunc-
tion was observed. Agatisa [34] reported that recurrent
episodes of elevated depressive symptoms were related to
a greater risk of coronary and aortic atherosclerosisamong those not yet diagnosed as having coronary dis-
ease. Some reports suggest the cardiac autonomic
dysfunction in depressed patients may increase the risk of
arrhythmia; which itself is a risk factor for coronary and
other cardiovascular disorders. Indeed, we demonstrated a
higher prevalence of arrhythmia in depressed patients
compared with controls; a finding that may go some way
to partially identifying a pathway by which depressed
individuals are at increased susceptibility to CVD onset.
That people with depression are more vulnerable to arrhy-
thmias, especially supraventricular arrhythmias, such as
single atrial premature beats, paired atrial premature beats
and single ventricular premature beats, is in general
agreement with the concept that there is a relationship be-
tween arrhythmia and emotional turbulence [35], which
may be related to increased sympathetic nervous system
activity [36]. Adrenergic secretion can increase the auto-
rhythmicity of heart purkinje fibers, reducing the excited
domain of the diastolic period and inducing sympathetic
excitability. As a result, it may increase the probability of
ventricular arrhythmia. Hyper-responsivity of sympathetic
nervous activity may also constitute a risk factor for the
development or progression of CVD [36].
Some of the inconsistencies in the evidence base
surrounding the relationship between HRV and depres-
sion may be explained by variance in study design, assess-
ment techniques and/or markers of autonomic functions
used across studies [37]. In this study, we analyzed HRV
and evaluated autonomic function through analysis of the
time-domain indexes SDNN, SDANN, RMSSD and
PNN50. The domain parameters of HRV used in this
study are considered a reliable indicator for risk of malig-
nant ventricular arrhythmias and sudden cardiac death
when compared with ventricular late potentials, left
ventricular ejection fraction, QT dispersion and the level
of cardiac function [38,39]. Altered HRV may therefore be
useful for predicting arrhythmia risk in patients with
depression.
We acknowledge several limitations of this study. Ours
was a sample taken from patients undergoing hospitali-
zation and subsequent treatment for major depression.
Based on the pre-determined selection criteria, they had
few anxiety symptoms, a low risk of suicide, and an
absence of acute myocardial infarction. While these
criteria were employed in order to reduce the impact of
confounding variables on our outcome of interest, this
selection bias may affect the generalizability of our
results. Secondly, the sample size was relatively small,
limiting our ability to analyse the relationship between
depression severity and HRV and perform meaningful
sub-group analyses. Although it should be acknowledged
that the markers of autonomic function are indirect
measures, the comprehensiveness of the data including
gold standard measures of depression using diagnostic
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ters are strengths of this study. Thirdly, the cross sectional
nature of the study does not allow examination of auto-
nomic dysfunction across the disease course to determine
whether remission affects this marker. Lastly, multiple
comparisons were not undertaken as part of our statistical
analyses; for example the effects of medication usage
remain undetermined as all patients in the depressed
group were receiving medication. We do acknowledge that
SSRI have been shown to impact on cardiac rhythm, thus
it is possible that using a sample comprising those on anti-
depressants may have diluted or alternatively, magnified
our findings, compared with a sample from the general
population, or using depressed individuals who were not
on medication. Therefore, results should be interpreted
with caution.Conclusions
Our findings suggest that depression is accompanied by
dysfunction of the cardiac autonomic nervous system,
and further, that depression severity is linked to severity
of this dysfunction. Individuals with depression appear
to be susceptible to premature atrial and/or ventricular
disease.
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